Pfizer Inc (PFIZ34) — Working Capital to Net Assets Ratio
Pfizer Inc (PFIZ34) has a Working Capital to Net Assets ratio of 9.4% as of March 2026. Working capital of R$8.47 Billion (current assets of R$42.82 Billion minus current liabilities of R$34.35 Billion) is measured against net assets of R$90.40 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Pfizer Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Pfizer Inc Working Capital to Net Assets (2014–2025)
This chart shows how Pfizer Inc's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of March 2026, the ratio stands at 9.4%, reflecting working capital of R$8.47 Billion against net assets of R$90.40 Billion BRL. See Pfizer Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Pfizer Inc (2014–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Pfizer Inc from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Pfizer Inc market capitalisation.
| Year | WC/NA Ratio | Working Capital (BRL) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 6.8% | R$5.91 Billion | R$86.78 Billion | R$42.90 Billion | R$36.98 Billion | ▼ -1.5 pp |
| 2024 | 8.3% | R$7.36 Billion | R$88.50 Billion | R$50.36 Billion | R$42.99 Billion | ▲ +13.3 pp |
| 2023 | -5.0% | R$-4.46 Billion | R$89.29 Billion | R$43.33 Billion | R$47.79 Billion | ▼ -14.5 pp |
| 2022 | 9.5% | R$9.12 Billion | R$95.66 Billion | R$51.26 Billion | R$42.14 Billion | ▼ -12.5 pp |
| 2021 | 22.0% | R$17.02 Billion | R$77.20 Billion | R$59.69 Billion | R$42.67 Billion | ▲ +7.6 pp |
| 2020 | 14.5% | R$9.15 Billion | R$63.24 Billion | R$35.07 Billion | R$25.92 Billion | ▲ +21.6 pp |
| 2019 | -7.1% | R$-4.50 Billion | R$63.14 Billion | R$32.80 Billion | R$37.30 Billion | ▼ -35.6 pp |
| 2018 | 28.5% | R$18.07 Billion | R$63.41 Billion | R$49.93 Billion | R$31.86 Billion | ▲ +13.5 pp |
| 2017 | 15.0% | R$10.71 Billion | R$71.31 Billion | R$41.14 Billion | R$30.43 Billion | ▲ +1.9 pp |
| 2016 | 13.2% | R$7.83 Billion | R$59.54 Billion | R$38.95 Billion | R$31.11 Billion | ▼ -9.0 pp |
| 2015 | 22.2% | R$14.41 Billion | R$65.00 Billion | R$43.80 Billion | R$29.40 Billion | ▼ -25.3 pp |
| 2014 | 47.5% | R$34.01 Billion | R$71.62 Billion | R$55.59 Billion | R$21.59 Billion | — |